August 6, 2027. That is the date Universal Pictures has locked for Snoop, the biographical film about Calvin Broadus Jr., and with it, the first theatrical project under Death Row Pictures' overall deal with NBCUniversal.
The deal itself was announced in 2022. Four years later, the label founded by Suge Knight in 1991, acquired by Broadus in 2022, and restructured as a production entity shortly after, will finally place a product in multiplexes. The timeline is worth noting: four years from corporate agreement to confirmed release window, in an era when IP-driven projects routinely move from announcement to screen in eighteen months.
Jonathan Daviss, known for Outer Banks, takes the title role. Craig Brewer directs. Neither is a surprise appointment. Brewer's Hustle & Flow (2005) and his work on the Dolemite Is My Name (2019) establish a track record with Black music narratives; Daviss's casting follows the biopic playbook of selecting television talent with range but not yet prohibitive theatrical quotes.
What the announcement does not mention is the catalog. Death Row's masters, including The Chronic, Doggystyle, and All Eyez on Me, represent one of the most valuable rap archives extant. The biopic functions as a delivery mechanism for those recordings into a theatrical marketing cycle, with soundtrack licensing, promotional partnerships, and streaming tie-ins to follow. Universal does not acquire a label's overall deal to produce a single film; it acquires access to the archive the film will reactivate.
The slot itself tells the story. August 6, 2027 was previously held for an untitled Universal event film. Snoop now occupies that position, meaning the studio is treating a hip-hop biopic as a tentpole, not counter-programming. That is a valuation statement. The last hip-hop biopic to open in a prime summer window at this scale was Straight Outta Compton, which Universal released in August 2015 to a $60 million opening weekend.
The production timeline underscores the deliberate pace of Death Row Pictures' studio integration. A four-year gap between corporate agreement and theatrical release suggests something other than development difficulty; it suggests asset positioning. When Broadus acquired the label, he inherited not just masters but dormant brand equity. Converting that equity into a studio partnership required restructuring Death Row from a music company into a production entity capable of generating filmed content. The biopic is the proof of concept for that conversion.
Brewer's selection reinforces the strategy. His prior work demonstrates not merely competence with Black music narratives but a specific capacity for translating catalog value into screen commerce. Hustle & Flow and Dolemite Is My Name both functioned as delivery vehicles for period soundtracks and archival recordings. The pattern is clear: hire a director whose filmography already serves as a template for what Death Row Pictures needs this project to accomplish. Daviss, cast from television rather than film, keeps the above-the-line budget disciplined enough to protect margin on a project whose real purpose is downstream licensing.
Eleven years between August hip-hop tentpoles. Death Row Pictures enters theatrical distribution with a studio that knows how to open this category, in a window that signals confidence. The film is not the point. The catalog reactivation is the point. August 6, 2027 is when that reactivation begins.